{
    "organizations": [],
    "uuid": "d9f73a9692a9490d6f6439b38c6abcee4c033425",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bayers-eylea-wins-first-regulatory/brief-bayers-eylea-wins-first-regulatory-approval-in-china-idUSF9N1PL00S",
    "ord_in_thread": 0,
    "title": "Bayer's Eylea Wins First Regulatory Approval In China",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - Bayer:\n* SAYS EYLEA APPROVED IN CHINA FOR TREATMENT OF DIABETIC MACULAR EDEMA, FIRST APPROVAL FOR EYLEA IN CHINA\nFurther company coverage:\n ",
    "published": "2018-02-13T17:04:00.000+02:00",
    "crawled": "2018-02-14T12:19:28.028+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "bayer",
        "say",
        "eylea",
        "approved",
        "china",
        "treatment",
        "diabetic",
        "macular",
        "edema",
        "first",
        "approval",
        "eylea",
        "china",
        "company",
        "coverage"
    ]
}